{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:20:03Z","timestamp":1788441603350,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/ki.2013.185","type":"journal-article","created":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T12:39:09Z","timestamp":1372855149000},"page":"998-1008","source":"Crossref","is-referenced-by-count":142,"title":["Use of phosphate-binding agents is associated with a lower risk of mortality"],"prefix":"10.1016","volume":"84","author":[{"given":"Jorge B.","family":"Cannata-And\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Fern\u00e1ndez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Gorriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ketteler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An\u00edbal","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boleslaw","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Memmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem-Jan","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Teplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Tielemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierik","family":"Verbeelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Kramar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf P.","family":"W\u00fcthrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drasko","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miha","family":"Benedik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Emilio","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mart\u00ednez-Camblor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Naves-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.185_bb0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/ki.2011.22","article-title":"50 years of research and discovery in chronic kidney disease and mineral & bone disorder: the central role of phosphate","volume":"121","author":"Slatopolsky","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2013.185_bb0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","article-title":"Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics","volume":"74","author":"Goodman","year":"2008","journal-title":"Kidney Int"},{"issue":"S113","key":"10.1038\/ki.2013.185_bb0020","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2013.185_bb0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/ndt\/17.5.723","article-title":"Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia","volume":"17","author":"Locatelli","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.185_bb0030","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.185_bb0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1681\/ASN.2008121277","article-title":"Phosphorus and survival: key questions that need answers","volume":"20","author":"Cannata-Andia","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0040","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1681\/ASN.2011020175","article-title":"Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition","volume":"22","author":"Zoccali","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0045","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1038\/ki.2013.185_bb0050","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","article-title":"Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study","volume":"26","author":"Naves-Diaz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.185_bb0055","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/ndt\/gfq128","article-title":"Mineral and bone disease pattern in elderly haemodialysis patients","volume":"25","author":"Pelletier","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.185_bb0060","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(01)06299-7","article-title":"Vascular calcification in chronic renal failure","volume":"358","author":"Goodman","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/ki.2013.185_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2009.09.006","article-title":"High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression","volume":"46","author":"Roman-Garcia","year":"2010","journal-title":"Bone"},{"issue":"S121","key":"10.1038\/ki.2013.185_bb0070","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1038\/ki.2011.24","article-title":"Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?","volume":"79","author":"Hruska","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2013.185_bb0075","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1359\/jbmr.091021","article-title":"Acute phosphate restriction leads to impaired fracture healing and resistance to BMP-2","volume":"25","author":"Wigner","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2013.185_bb0080","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archinte.167.9.873","article-title":"Phosphorus comes of age as a cardiovascular risk factor","volume":"167","author":"Foley","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.2013.185_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1038\/ki.2013.185_bb0090","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.2215\/CJN.05880809","article-title":"Ten-year experience with sevelamer and calcium salts as phosphate binders","volume":"5","author":"Raggi","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2215\/CJN.05060610","article-title":"Comparative effectiveness of calcium-containing phosphate binders in incident US dialysis patients","volume":"6","author":"Winkelmayer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0105","series-title":"Nephrol Dial Transplant","article-title":"Instrumental variable analysis","author":"Stel","year":"2012"},{"key":"10.1038\/ki.2013.185_bb0110","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1097\/01.ASN.0000100127.54107.57","article-title":"Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"14","author":"Goodkin","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0115","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2005111241","article-title":"Increasing body mass index and obesity in the incident ESRD population","volume":"17","author":"Kramer","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ndt\/gfg418","article-title":"Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Hecking","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.185_bb0125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2011.12.025","article-title":"Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status","volume":"60","author":"Lopes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.185_bb0130","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","article-title":"Meta-analysis: vitamin D compounds in chronic kidney disease","volume":"147","author":"Palmer","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2013.185_bb0135","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ki.2008.343","article-title":"Oral active vitamin D is associated with improved survival in hemodialysis patients","volume":"74","author":"Naves-Diaz","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.185_bb0140","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1038\/ki.2013.185_bb0145","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2215\/CJN.04720709","article-title":"International hemodialysis patient outcomes comparisons revisited: the role of practice patterns and other factors","volume":"4","author":"Robinson","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0150","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2215\/CJN.00810110","article-title":"Serum phosphate and mortality in patients with chronic kidney disease","volume":"5","author":"Eddington","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0155","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.2215\/CJN.03780411","article-title":"Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients","volume":"6","author":"Zitt","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"S95","key":"10.1038\/ki.2013.185_bb0160","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1111\/j.1523-1755.2005.09502.x","article-title":"Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis","volume":"67","author":"Nolan","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2013.185_bb0165","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.20781","article-title":"Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial","volume":"52","author":"Garg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2013.185_bb0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2215\/CJN.02810707","article-title":"Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients","volume":"3","author":"Caglar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0175","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.185_bb0180","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/ndt\/gfr144","article-title":"Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients","volume":"26","author":"Gonzalez-Parra","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.185_bb0185","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1744-9987.2005.00293.x","article-title":"Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients","volume":"9","author":"Koiwa","year":"2005","journal-title":"Ther Apher Dial"},{"issue":"Suppl 3","key":"10.1038\/ki.2013.185_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ndt\/11.supp3.69","article-title":"Aluminium toxicity: its relationship with bone and iron metabolism","volume":"11","author":"Cannata-And\u00eda","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"10.1038\/ki.2013.185_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ndt\/17.suppl_2.9","article-title":"The clinical impact of aluminium overload in renal failure","volume":"17","author":"Cannata-Andia","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1038\/ki.2013.185_bb0200","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.2215\/CJN.05860809","article-title":"Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population","volume":"5","author":"West","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0205","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"key":"10.1038\/ki.2013.185_bb0210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1038\/ki.2013.185_bb0215","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2215\/CJN.06140809","article-title":"Calcium in chronic kidney disease: myths and realities. Introduction","volume":"5","author":"Langman","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0220","first-page":"286","article-title":"Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease Stage 5 receiving hemodialysis","volume":"71","author":"Hutchison","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2013.185_bb0225","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1185\/03007990903399398","article-title":"Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy","volume":"25","author":"Wilson","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1038\/ki.2013.185_bb0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2215\/CJN.02830608","article-title":"Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial","volume":"4","author":"Sprague","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.185_bb0235","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5414\/CNP72252","article-title":"Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study","volume":"72","author":"Sprague","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2013.185_bb0240","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.2010.23","article-title":"Efficacy and safety of SBR759, a new iron-based phosphate binder","volume":"77","author":"Block","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.185_bb0245","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/ndt\/gfr034","article-title":"Phosphate binders in a European haemodialysis population","volume":"26","author":"Jean","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.185_bb0250","series-title":"Nephrol Dial Transplant","article-title":"COSMOS: The dialysis scenario of CKD-MBD in Europe","author":"Fern\u00e1ndez-Mart\u00edn","year":"2012"},{"key":"10.1038\/ki.2013.185_bb0255","first-page":"290","article-title":"Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS)","volume":"21","author":"Cannata-Andia","year":"2008","journal-title":"J Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815560584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815560584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T19:00:09Z","timestamp":1715626809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815560584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0085253815560584"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.185","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}